The effect of omega-3 fatty acid supplementation on seizure frequency in individuals with epilepsy: a systematic review and meta-analysis

References

• Cunnane S, Musa K, Ryan M, Whiting S, Fraser D. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins, Leukotrienes Essent Fatty Acids. 2002;67(2-3):131–5.
   PubMed Web of Science ®Google Scholar
• Scorza CA, Cavalheiro EA, Scorza FA. The prescription of omega-3 fatty acids for people with epilepsy by Brazilian epileptologists: We know the goal, but do we know the price? Epilepsy Behav. 2013;27(2):422–3.
   PubMed Web of Science ®Google Scholar
• Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon C-S, Dykeman J, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303.
   PubMed Web of Science ®Google Scholar
• Ngugi AK, Kariuki S, Bottomley C, Kleinschmidt I, Sander J, Newton C. Incidence of epilepsy: a systematic review and meta-analysis. Neurology. 2011;77(10):1005–12.
   PubMed Web of Science ®Google Scholar
• Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. Neuropsychiatr Dis Treat. 2016;12:467–85.
   PubMed Web of Science ®Google Scholar
• Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults. Med J Aust. 2018;208(5):226–33.
   PubMed Web of Science ®Google Scholar
• Begley CE, Durgin TL. The direct cost of epilepsy in the United States: a systematic review of estimates. Epilepsia. 2015;56(9):1376–87.
   PubMed Web of Science ®Google Scholar
• Yuen AW, Sander JW, Fluegel D, Patsalos PN, Bell GS, Johnson T, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav. 2005;7(2):253–8.
   PubMed Web of Science ®Google Scholar
• Ibrahim FA, Ghebremeskel K, Abdel-Rahman ME, Ahmed AA, Mohmed IM, Osman G, et al. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy—A randomized, double-blind, placebo-controlled trial. Epilepsy Behav. 2018;87:32–8.
   PubMed Web of Science ®Google Scholar
• Mirnikjoo B, Brown SE, Kim HFS, Marangell LB, Sweatt JD, Weeber EJ. Protein kinase inhibition by ω-3 fatty acids. J Biol Chem. 2001;276(14):10888–96.
   PubMed Web of Science ®Google Scholar
• Watson RR. Omega-3 fatty acids in brain and neurological health. Boston: Elsevier; 2014.
   Google Scholar
• DeGiorgio CM, Scorza FA. Epilepsy & behavior: 15th anniversary research on omega-3 fatty acids for epilepsy. Epilepsy Behav. 2014;40:124–5.
   PubMed Web of Science ®Google Scholar
• Yuen AW, Sander JW, Flugel D, Patsalos PN, Browning L, Bell GS, et al. Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? Epilepsy Behav. 2008;12(2):317–23.
   PubMed Web of Science ®Google Scholar
• Bourre JM, Pascal G, Durand G, Masson M, Dumont O, Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem. 1984;43(2):342–8.
   PubMed Web of Science ®Google Scholar
• Omrani S, Taheri M, Omrani MD, Arsang-Jang S, Ghafouri-Fard S. The effect of omega-3 fatty acids on clinical and paraclinical features of intractable epileptic patients: a triple blind randomized clinical trial. Clin Transl Med. 2019;8(1):3.
   PubMedGoogle Scholar
• Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000;19(8):1784–93.
   PubMed Web of Science ®Google Scholar
• Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr. 2011;31:321–51.
   PubMed Web of Science ®Google Scholar
• Bernardino L, Ferreira R, Cristovao A, Sales F, Malva J. Inflammation and neurogenesis in temporal lobe epilepsy. Current Drug Targets-CNS Neurol Disorders. 2005;4(4):349–60.
   PubMedGoogle Scholar
• Vreugdenhil M, Bruehl C, Voskuyl R, Kang J, Leaf A, Wadman W. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA. 1996;93(22):12559–63.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Higgins J, Wells G. Cochrane handbook for systematic reviews of interventions. 2011.
   Google Scholar
• Schwingshackl L, Knuppel S, Schwedhelm C, Hoffmann G, Missbach B, Stelmach-Mardas M, et al. Perspective: nutriGrade: a scoring system to assess and judge the meta-evidence of randomized controlled trials and cohort studies in nutrition research. Adv Nutr. 2016;7(6):994–1004.
   PubMed Web of Science ®Google Scholar
• Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www.cochrane-handbook.org. 2011.
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629–34.
   PubMed Web of Science ®Google Scholar
• Fallah R, Eiliaei S, Ferdosian F. Clinical trial of efficacy evaluation of omega-3 with risperidone on seizures frequency in children with refractory epilepsy and attention-deficit/hyperactivity disorder. Iran J Child Neurol. 2018;12(4):28.
   PubMed Web of Science ®Google Scholar
• DeGiorgio CM, Miller PR, Harper R, Gornbein J, Schrader L, Soss J, et al. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. J Neurol Neurosurg Psych. 2015;86(1):65–70.
   PubMed Web of Science ®Google Scholar
• Yuen AW, Flugel D, Poepel A, Bell GS, Peacock JL, Sander JW. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy Behav. 2012;23(3):370–2.
   PubMed Web of Science ®Google Scholar
• Al Khayat HA, Awadalla MM, Al Wakad A, Marzook ZA. Polyunsaturated fatty acids in children with idiopathic intractable epilepsy: serum levels and therapeutic response. J Pediatr Neurol. 2010;8(2):175–85.
   Google Scholar
• DeGiorgio CM, Miller P, Meymandi S. Gornbein JA. n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav. 2008;13(4):681–4.
   PubMed Web of Science ®Google Scholar
• Spooner MH, Jump DB. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? Curr Opin Clin Nutr Metab Care. 2019;22(2):103.
   PubMed Web of Science ®Google Scholar
• Pourmasoumi M, Vosoughi N, Derakhshandeh-Rishehri S-M, Assarroudi M, Heidari-Beni M. Association of omega-3 fatty acid and epileptic seizure in epileptic patients: A systematic review. Int J Prev Med. 2018;9:36–44.
   PubMed Web of Science ®Google Scholar
• Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia. 2002;43(1):103–4.
   PubMed Web of Science ®Google Scholar
• Bromfield E, Dworetzky B, Hurwitz S, Eluri Z, Lane L, Replansky S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 2008;12(1):187–90.
   PubMed Web of Science ®Google Scholar
• [36] Scorza FA, Cysneiros RM, Terra VC, Scorza CA, Cavalheiro EA, Ribeiro MO, et al. Omega-3 consumption and sudden cardiac death in schizophrenia. Prostaglandins Leukotrienes Essent Fatty Acids. 2009;81(4):241–5.
   PubMed Web of Science ®Google Scholar
• Zirpoli H, Chang CL, Carpentier YA, Michael-Titus AT, Ten VS, Deckelbaum RJ. Novel approaches for omega-3 fatty acid therapeutics: chronic versus acute administration to protect heart, brain, and spinal cord. Annu Rev Nutr. 2020;40:161–87.
   PubMed Web of Science ®Google Scholar
• Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol. 1994;254(1-2):193–8.
   PubMed Web of Science ®Google Scholar
• Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 2011;44(2):216.
   PubMed Web of Science ®Google Scholar
• Bazan NG. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid the proctor lecture. Invest Ophthalmol Visual Sci. 2007;48(11):4866–81.
   PubMed Web of Science ®Google Scholar
• DeGiorgio CM, Taha AY. Omega-3 fatty acids (ῳ-3 fatty acids) in epilepsy: animal models and human clinical trials. Expert Rev Neurother. 2016;16(10):1141–5.
   PubMed Web of Science ®Google Scholar
• Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol. 1998;341(2-3):145–52.
   PubMed Web of Science ®Google Scholar
• Kaplan DI, Isom LL, Petrou S. Role of sodium channels in epilepsy. Cold Spring Harbor Perspect Med. 2016;6(6):a022814.
   PubMed Web of Science ®Google Scholar
• Yogeeswari P, Ragavendran JV, Thirumurugan R, Saxena A, Sriram D. Ion channels as important targets for antiepileptic drug design. Curr Drug Targets. 2004;5(7):589–602.
   PubMed Web of Science ®Google Scholar
• Xiao Y-F, Gomez AM, Morgan JP, Lederer W, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 1997;94(8):4182–7.
   PubMed Web of Science ®Google Scholar